Long awaited university-based venture fund expected to launch soon
After a three year search, the OSU-OU venture capital fund looks like it will name John Steuart the head in the coming weeks.
Ohio State, Ohio University partner on $35M venture fund
Ohio State University and Ohio University are creating a $35 million venture capital fund aimed at commercializing research that comes out of universities in the state. California-based Dominion Ventures will be the fund’s general partner, according to a statement from the two universities. An official with Dominion wasn’t available for comment. Ohio State plans to […]
Ohio University incubator now includes biotech support, services
A business incubator on Ohio University’s campus is opening section that will include biotechnology support and other components. The Ohio University Innovation Center‘s new biotech research and development facility will feature “state-of-the-art instrumentation and research equipment for chemical and biomedical analysis,” according to the university. The new biotech expansion is intended for use by OU […]
Target: Superbugs. Ohio drug startup focused on MRSA infection
An Ohio startup is developing a new antibacterial drug that would keep so-called “superbugs” such as MRSA from replicating in the body. Promiliad Biopharma is hoping its early development efforts yield a new drug capable of beating bacteria that have grown resistant to most antibiotics on the market today. The most well-known example is a […]
Ohio U. spinoff Sanuthera developing iPod-like tinnitus therapy device
An Ohio University startup is developing a medical device it hopes will represent a breakthrough in treating patients suffering from tinnitus, a ringing or buzzing in the ears. Sanuthera’s device involves wireless ear buds connected to an MP3 player that can be customized to a patient’s preference to play a number of sounds aimed at […]
Ohio University med school gets $105M gift, largest ever for an Ohio college
Ohio University‘s medical school will use a $105 million gift to establish a new campus in Central Ohio with an eye toward boosting the number of primary care doctors in the state. The gift, which university officials described as the largest ever for an Ohio institution of higher learning, comes from the Osteopathic Heritage Foundations, […]
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Ohio University licenses drug candidates to N.Y. firm in $600k deal
The deal with Phosplatin Therapeutics could lead to the development of a new ovarian cancer therapeutic, and more royalty income for Ohio University.
Is a $100M university venture capital fund coming to Ohio?
Ohio State University officials are talking up an idea for a $100 million venture capital fund that'd be structured as a partnership between the state's public universities and private industry.
Can Interthyr be Ohio U’s next commercialization success story?
While there's plenty of optimism surrounding Interthyr, it'll be awhile before university officials know what kind of potential they're sitting on. No human testing of the company's drug candidate for cancer and autoimmune disorders has occurred yet, and it's unlikely to happen until 2012.
Ohio University pulls in $8.2M from research licensing
Ohio University received $8.2 million in fiscal 2010 from licensing technologies that were discovered by its researchers, an increase of 19 percent from last year. The vast majority of that revenue–about $8 million–came from from Pfizer Corp. from a license for a growth hormone antagonist that became the basis for the drug Somavert, according to a […]
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Quidel Corp. completes acquisition of Diagnostic Hybrids in Athens, Ohio, for $130M
San Diego diagnostic test maker Quidel Corp. has closed its acquisition of Diagnostic Hybrids Inc. for about $130 million in cash. Announced in mid-January, the acquisition is expected to add depth and innovation to Quidel's line of rapid, point-of-care tests for pregnancy, infectious diseases, cancer, bone health and autoimmune disorders.
Governor, chancellor announce Ohio’s bioscience, health care centers of excellence
Gov. Ted Strickland and Ohio Board of Regents Chancellor Eric Fingerhut donned their high-tech marketing hats Friday, touting the state's leadership in biomedical and health care innovation by announcing centers of excellence at 14 universities.
Night Read (Ohio): Austen BioInnovation Institute partners with Orthopaedic Research Laboratories
The Austen BioInnovation Institute in Akron has struck a strategic partnership with Cleveland orthopedic device testing and design firm Orthopaedic Research Laboratories to discover, develop and commercialize novel technologies and solutions that advance orthopedic care.
Night Read (Ohio): MedWish collect supplies; doctors, nurses volunteer for Haiti
MedWish International still is collecting medical supplies for victims of the Haitian earthquake while Ohio doctors, nurses and other medical professionals volunteer to help.
Technology transfer grows at U.S. research institutions
Technology transfer -- moving research out of institutions and into companies that can develop and market products with it -- was a healthy enterprise nationwide in fiscal 2007. Northeast Ohio institutions were more successful than those elsewhere in the state at leveraging research spending with licensing revenues.